drugset / Trial / NCT04849247
68Ga-DOTA-FAPI and 177Lu-DOTA-FAPI Theranostic Pair in Patients With Various Types of Cancer (Locally Advanced or Metastatic Cancer)
RandomizedSequentialOpen-labelTreatment
Summary
This is a Phase I, first-in-human study to evaluate the safety and efficacy of the 68Ga-DOTA-FAPI and 177Lu-DOTA-FAPI theranostic pair in patients with various types of cancer (locally advanced or metastatic cancer).
Timeline
- Start
- 2021-04-13
- Primary completion
- 2024-04-15
- Completion
- 2024-04-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 177Lu-DOTA-FAPI | Unknown | 30 unknown | — |
| Subject | 177Lu-DOTA-FAPI | Unknown | 150 unknown | — |
| Subject | 68Ga-DOTA-FAPI | Diagnostic / imaging agent | — | — |
Indications
No indication recorded.